Logo of brjpharmLink to Publisher's site
PMC full text:

Table 2

Pharmacokinetics of tea flavanols and their plasma metabolites in humans

Ingested doseDetected compoundCmaxTmax (h)References
GTEGCG 63–328.5 mgEGCG55–711 nM1.3–2.7 http://phenol‐explorer.eu/, Williamson et al., 2011; Clifford et al., 2013; Del Rio et al., 2013
GTEGC 32–306 mgEGC40–1791 nM1.3–2.2 http://phenol‐explorer.eu/, Williamson et al., 2011; Clifford et al., 2013; Del Rio et al., 2013
GTEC 12–113 mgEC29–655 nM1.4–1.8 http://phenol‐explorer.eu/, Williamson et al., 2011; Clifford et al., 2013; Del Rio et al., 2013
GTflavanols 32–154 mgMethyl‐EGC62–5300 nM2–2.3 http://phenol‐explorer.eu/, Williamson et al., 2011; Clifford et al., 2013; Del Rio et al., 2013
GTflavanols 12–17 mgMethyl‐EC‐sulfate14–90 nM1.3–1.7 http://phenol‐explorer.eu/, Williamson et al., 2011; Clifford et al., 2013; Del Rio et al., 2013
GTFlavanols 648 μM in 500 mLEC‐glucuronide29 nM1.7 http://phenol‐explorer.eu/, Williamson et al., 2011; Clifford et al., 2013; Del Rio et al., 2013
EC‐sulfates89 nM1.6
EGC‐glucuronide126 nM2.2
Met‐EGC‐glucuronide46 nM2.3
TFs700 mg dissolved in 150 mL hot water:Theaflavins≈1 μg·L−1 2 http://phenol‐explorer.eu/, Mulder et al., 2001
TF 123.9·700 mg−1 DW
TF3G 222.6·700 mg−1 DW
TF3'G 116.9·700 mg−1DW
TFDG 219.8·700 mg−1DW

Cmax, peak‐plasma concentrations; DW, dry weight; TF, theaflavin; TF3G, theaflavin 3‐O‐gallate; TF3′G, theaflavin 3′‐O‐gallate; TFDG, theaflavin 3,3′‐O‐digallate; Tmax, time at which the Cmax is observed.

-